
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 12 1117-1121, Copyright © 1998 by American Association for Cancer Research
ARTICLES |
BG Sleckman, PM Mauch, RF Ambinder, R Mann, GS Pinkus, ME Kadin, B Sherburne, A Perez-Atayde, I Thior and N Mueller
Harvard Medical School, Boston, Massachusetts 02115, USA.
Risk factors suggestive of relatively late exposure to EBV have been consistently associated with Hodgkin's disease (HD) in younger adults. In addition, evidence of EBV infection has been found in the Reed-Sternberg cells themselves in about one-third to one-half of all HD cases. However, no study yet published has correlated these childhood social environment risk factors with the presence of EBV in Hodgkin's tumor cells. We examined whether EBV-positive HD occurs in those patients whose childhood environment would predispose them to relatively late exposure to EBV. The study population consisted of 102 cases of mixed cellularity (MC; n = 25) or nodular sclerosing (n = 77) HD. Samples that tested positive for either EBV-encoded RNA or latent membrane protein or both were considered EBV-positive. Of the 102 cases, 83 completed a questionnaire regarding childhood social environment. The association with EBV-positivity was estimated by the odds ratio (OR) with 95% confidence intervals (CI). Twenty-two percent of the cases were EBV-positive. These cases were more likely to be MC (OR, 6.2; CI, 2.3-16.3) and male (OR, 3.4; CI, 1.3-9.0). History of infectious mononucleosis (IM) was not predictive of EBV-positivity, with only 3 of 14 such patients being EBV-positive (P = 0.82). Contrary to our hypothesis, no association between EBV and childhood environment risk factors was identified. The association of EBV with MC histology and male gender agrees with previous reports. The most intriguing finding was the dissociation between IM history and EBV-positivity, in that almost all of the cases with a history of IM were EBV-negative.
This article has been cited by other articles:
![]() |
H. Hjalgrim, K. Ekstrom Smedby, K. Rostgaard, D. Molin, S. Hamilton-Dutoit, E. T. Chang, E. Ralfkiaer, C. Sundstrom, H.-O. Adami, B. Glimelius, et al. Infectious Mononucleosis, Childhood Social Environment, and Risk of Hodgkin Lymphoma Cancer Res., March 1, 2007; 67(5): 2382 - 2388. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Kadin and C. Carpenter Hidden identity of Hodgkin/Reed-Sternberg cells Blood, January 1, 2004; 103(1): 7 - 7. [Full Text] [PDF] |
||||
![]() |
H. Hjalgrim, J. Askling, K. Rostgaard, S. Hamilton-Dutoit, M. Frisch, J.-S. Zhang, M. Madsen, N. Rosdahl, H. B. Konradsen, H. H. Storm, et al. Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis N. Engl. J. Med., October 2, 2003; 349(14): 1324 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hjalgrim, K. Rostgaard, J. Askling, M. Madsen, H. H. Storm, C. S. Rabkin, and M. Melbye Hematopoietic and Lymphatic Cancers in Relatives of Patients With Infectious Mononucleosis J Natl Cancer Inst, May 1, 2002; 94(9): 678 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Alexander, R. F. Jarrett, R. A. Cartwright, A. A. Armstrong, D. A. Gokhale, E. Kane, D. Gray, D. J. Lawrence, and G. M. Taylor Epstein-Barr Virus and HLA-DPB1-*0301 in Young Adult Hodgkin's Disease: Evidence for Inherited Susceptibility to Epstein-Barr Virus in Cases that Are EBV+ve Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 705 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yasui, J. D. Potter, J. L. Stanford, M. A. Rossing, M. D. Winget, M. Bronner, and J. Daling Breast Cancer Risk and "Delayed" Primary Epstein-Barr Virus Infection Cancer Epidemiol. Biomarkers Prev., January 1, 2001; 10(1): 9 - 16. [Abstract] [Full Text] |
||||
![]() |
H. Hjalgrim, J. Askling, P. Sorensen, M. Madsen, N. Rosdahl, H. H. Storm, S. Hamilton-Dutoit, L. S. Eriksen, M. Frisch, A. Ekbom, et al. Risk of Hodgkin's Disease and Other Cancers After Infectious Mononucleosis J Natl Cancer Inst, September 20, 2000; 92(18): 1522 - 1528. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |